QUOTED. 3 February 2020. Stephen Hahn.
Executive Summary
The new US Food and Drug Administration commissioner has outlined his top priorities for the agency, including the use of data and patient input to guide regulatory decisions, and feedback from staff on how to improve the agency. See what the agency's commissioner, Stephen Hahn, said about it here.
“I will do everything I can to ensure that the FDA has the resources – human, financial, and operational – to take on these challenges.” – Stephen Hahn, commissioner, US FDA
- Find out more: In Letter To FDA Staff, Hahn Lays Out His Cards
Click here for a free trial of Medtech Insight